Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders

To participate in this activity, please:

Primary headache disorders are a major cause of disability and a common reason people seek medical care. However, distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting. Insight is also provided to help guide treatment with evidence-based medications and devices, including new options. The real-world use of shared decision-making to individualize patient management and improve patient outcomes is brought to life through the use of whiteboard animation.

Course Credit:

1.50 ACPE Contact Hours
1.50 AMA PRA Category 1 CreditsTM
1.50 ANCC Contact Hours

Dates:

Opens: 2020-12-14
Closes: 2021-12-14

Target Audience:

This activity was developed for headache specialists, neurologists, primary care physicians, pain specialists, OB/GYNs, nurses, nurse practitioners, physician assistants, pharmacists, medical students, residents, and other clinicians who care for patients with primary headache disorders.

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
  • Jessica Ailani, MD, FAHS

    Director
    MedStar Georgetown Headache Center
    Associate Professor of Neurology Medstar Georgetown University Hospital
    Washington, DC

  • Gregory Scott, PharmD

    WriteHealth, LLC
    Kennebunk, Maine

  • Stewart J. Tepper, MD

    Professor of Neurology
    Geisel School of Medicine at Dartmouth
    Hanover, New Hampshire
    Director, Dartmouth Headache Center
    Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire

Learning Objectives

  • Apply guideline-based diagnostic and evaluation strategies to diagnose and differentiate migraine from cluster headache and other primary and secondary headache disorders
  • Evaluate acute and preventative pharmacological therapies to develop an individualized treatment plan
  • Foster stronger patient adherence through shared decision
  • Utilize the shared decision-making process with patients who have a primary headache disorder to individualize treatment

Faculty Disclosures

Jessica Ailani, MD, FAHS

Advisory Board

  • AbbVie, Axsomem, Biohaven, Impel, Lilly, Satsuma,Teva

Consultant

  • AbbVie, Biohaven, Lilly, Lundbeck, Satsuma

Research Support

  • AbbVie, Biohaven, Lilly, Zosano

Speakers Bureau

  • AbbVie, Biohaven, Lilly, Lundbeck, Teva

Gregory Scott, PharmD

No significant relationship to disclose


Stewart J. Tepper, MD

Research Support

  • Allergan, Amgen, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, Lundbeck, Neurolief, Novartis, Satsuma, Scion Neurostim, Teva, Zosano

Consultant and/or Advisory Board

  • Acorda, Aeon, Alexza, Align Strategies, Allergan, Alphasights, Amgen, Aperture Venture Partners, Aralez Pharmaceuticals Canada, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, Charleston Labs, CRG, Currax, Decision Resources, DeepBench, Eli Lilly, eNeura, Equinox, ExpertConnect, GLG, GSK, Guidepoint Global, Healthcare Consultancy Group, Health Science Communications, Impel, Lundbeck, M3 Global Research, Magellan Rx Management, Marcia Berenson Connected Research and Consulting, Medicxi, Navigant Consulting, Neurolief, Nordic BioTech, Novartis,  Pulmatrix, Reckner Healthcare, Relevale, Revance, SAI MedPartners, Satsuma, Scion Neurostim, Slingshot Insights, Sorrento, Spherix Global Insights, Sudler and Hennessey, Synapse Medical Communications, Teva, Theranica, Thought Leader Select, Trinity Partners, XOC, Zosano

Stock options

  • Nocira, Percept

Accreditation and Certification

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-0000-20-118-H01-P. This program is designated for up to 0 contact hour (0.1 CEUs) of continuing pharmacy education credit.
The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.50 contact hours may be earned for successful completion of this activity.

Additional Content Planners

Eugene Cullen, MD (Peer Reviewer)

No significant relationship to disclose


Heather M. Jimenez, FNP-C (Nurse Planner)
No significant relationships to disclose.

Gregory Scott, PharmD, RPh (Medical Writer)
No significant relationships to disclose.

Annenberg Center for Health Sciences

All members of the Eisenhower Health Education Committee have no relevant commercial relationships to disclose.